Troyen A. Brennan - 15 Jun 2021 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Chief Medical Officer
Signature
/s/ Troyen Brennan
Issuer symbol
CVS
Transactions as of
15 Jun 2021
Net transactions value
-$1,723,457
Form type
4
Filing time
17 Jun 2021, 17:04:48 UTC
Previous filing
10 May 2021
Next filing
07 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Options Exercise $4,086,015 +65,681 +45% $62.21 210,378 15 Jun 2021 Direct
transaction CVS Common Stock Sale $5,809,472 -67,552 -32% $86.00 142,826 15 Jun 2021 Direct F1
holding CVS Common Stock (restricted) 4,805 15 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Options Exercise $0 -65,681 -75% $0.000000 21,894 15 Jun 2021 Common Stock 65,681 $62.21 Direct F2
holding CVS Stock Option 47,937 15 Jun 2021 Common Stock 47,937 $102.26 Direct F3
holding CVS Stock Option 53,772 15 Jun 2021 Common Stock 53,772 $104.82 Direct F4
holding CVS Stock Option 75,134 15 Jun 2021 Common Stock 75,134 $78.05 Direct F5
holding CVS Stock Option 161,605 15 Jun 2021 Common Stock 161,605 $54.19 Direct F6
holding CVS Stock Option 112,637 15 Jun 2021 Common Stock 112,637 $58.34 Direct F7, F8
holding CVS Stock Option 99,344 15 Jun 2021 Common Stock 99,344 $74.30 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All sales were effected pursuant to a Rule 10b5-1 plan.
F2 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F3 Option became exercisable in four equal annual installments, commencing 4/1/2016.
F4 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F5 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F6 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7 The number of shares subject to the option were calculated using a 30-day average price.
F8 Options became exercisable in four equal annual installments, commencing 4/1/2021.
F9 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.